FDA, Industry Discuss Regulatory Impacts Of Infusion Pump Safety Steps
This article was originally published in The Gray Sheet
Executive Summary
Imposing more stringent pre-market requirements on external infusion pumps may help reduce recalls, but could also slow market entry for safer pump designs, according to industry speakers at an FDA workshop
You may also be interested in...
Assurance Cases Are Slowing Down Infusion Pump Submissions, Branch Chief Says
The need for infusion pump manufacturers to prepare safety cases is slowing down 510(k) submissions for the products, said Richard Chapman, the head of CDRH's General Hospital Devices review branch.
Assurance Cases Are Slowing Down Infusion Pump Submissions, Branch Chief Says
The need for infusion pump manufacturers to prepare safety cases is slowing down 510(k) submissions for the products, said Richard Chapman, the head of CDRH's General Hospital Devices review branch.
Device Analysts See Tougher Mandates, More Recalls On Regulatory Horizon
Device industry analysts say the FDA regulatory environment will get more challenging before eventually stabilizing, resulting in hazier pre-market requirements, tougher manufacturing inspections and more Class I recalls, among other burdens